If enacted, H8120 will significantly amend the existing statutes governing health insurance policies, enhancing the rights of women seeking infertility assistance. This amendment will help alleviate some of the financial challenges posed by infertility treatments, which can often be prohibitively expensive. Additionally, the bill could set a precedent for further health insurance reforms in the state, particularly concerning comprehensive coverage for women's reproductive health needs.
Summary
House Bill H8120 addresses the coverage of infertility treatments under health insurance policies in the state of Rhode Island. The bill mandates that all health insurance contracts in the state that provide pregnancy-related benefits must include coverage for the medically necessary expenses related to the diagnosis and treatment of infertility for women between the ages of 25 and 42. Importantly, this includes expenses related to in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD). The bill aims to ensure that women facing infertility have greater access to necessary medical interventions without undue financial burden.
Contention
While the bill seeks to broaden insurance coverage for infertility treatments, it may face opposition from some insurance providers who argue that such mandates could increase premiums. Critics of mandated coverage often cite concerns about potential overreach into the autonomy of insurance companies to design their plans. Furthermore, setting a lifetime cap on coverage for these treatments at $100,000 might also invite debate about whether this amount is adequate for individuals facing complex infertility issues, wherein costs can escalate significantly beyond this limit due to varied medical conditions.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance plans provide insurance coverage for diagnosing and treating infertility for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).
Mandates all insurance plans provide insurance coverage for diagnosing and treating infertility for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).